On the morning of October 19, 2017, Shao Yuanchang, Deputy Director of the Provincial Food and Drug Administration, Chen Yuehua, Director of the Safety Supervision Division, Wang Weidong, Director of the Certification and Inspection Center, and other members of the delegation, accompanied by Xia Haiguo, Director of the Market Supervision Bureau, visited Zhejiang Benefit Pharmaceutical for research and guidance, and a symposium was held.

Accompanied by the company's senior management, Deputy Director Shao and his entourage inspected various production workshops and laboratories of the enterprise, gaining an in-depth understanding of the production, R&D, and quality control measures of the enterprise's traditional Chinese medicine formula granules.

At the symposium, Chairman Wu Lihua gave a detailed report to Deputy Director Shao and his delegation on the company's development and production status, with a focus on introducing the production progress of "traditional Chinese medicine formula granules" and the layout plan for the company's future development.

After listening to the report, Director Xia stated that as the first pilot manufacturer of "traditional Chinese medicine formula granules" in Lishui, Zhejiang Benefit Pharmaceutical should solidly focus on its main business, prioritize ensuring product quality, improving production processes, and optimizing the production environment, earnestly carry out the production and promotion of "traditional Chinese medicine formula granules", effectively promote the development of the traditional Chinese medicine industry in Lishui, drive the Chinese medicinal materials planting industry, and increase farmers' income.

After the on-site research, Deputy Director Shao put forward requirements for the future development of Benefit Pharmaceutical.

Benefit Pharmaceutical should lay a solid foundation, leverage Lishui's unique advantages, and promote the development of Lishui's green ecological industry. Product quality is the foundation of an enterprise's development. It is necessary to strengthen the awareness of product quality control, improve product quality, and work together to promote the healthy and standardized development of traditional Chinese medicine formula granules in Zhejiang Province.

Finally, the chairman stated that Benefit Pharmaceutical will always adhere to its original aspiration and go all out to advance the traditional Chinese medicine formula granules project.

Traditional Chinese medicine formula granules are not just a product, but more of a culture.